Table 3.
Patient number | Monthly long episodes at first month | Average daily activations during first month | Monthly long episodes at last follow-up | % reduction in monthly long episodes at last follow-up | Average daily activations at last follow-up | % change in daily activations at last follow-up | Last follow-up (months) |
---|---|---|---|---|---|---|---|
1 | 19 | 1,300 | 16 | 16% | 900 | 31% | 10.7 |
2 | 32 | 2,000 | 41 | −28% | 2,100 | −5% | 7.4 |
3 | 4 | 1,250 | 2 | 50% | 500 | 60% | 7.6 |
4 | 43 | 1,000 | 52 | −21% | 1,500 | −50% | 9.0 |
5 | 1 | 240 | 0 | 100% | 35 | 85% | 9.4 |
8 | 0 | 800 | 3 | N/A | 500 | 38% | 5.7 |
9 | 12 | 150 | 0 | 100% | 200 | −33% | 4.6 |
10 | 9 | 1,000 | 12 | −33% | 1,250 | −25% | 3.4 |
In our preliminary short-term follow-up (median 7.5 months), mean seizure frequency reduction at last follow-up was 26%. Patients 6 and 7 had insufficient data for seizure outcome collection.